NUDT16 and hepatocellular carcinoma: As shown in Figures 7, L–N and S3, L and M, HMGA1 or NUDT16 knockdown alone, and HMGA1-NUDT16 double knockdown all enhanced the sensitivity of HCC-LM3 cells to cisplatin and IR treatment compared to the control group.